- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06076551
Sex Difference of Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease
Sex Difference of Coronary Microvascular Dysfunction Evaluated by Coronary Flow Reserve in Patients With Non-obstructive Coronary Artery Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will select consecutive patients who experienced chest pain but had no significant coronary artery stenosis (<50% stenosis). Coronary microvascular function will be evaluated by adenosine stress echocardiography. Coronary blood flow velocities will be measured at 1, 2, and 3 min after adenosine infusion.
Sex difference of coronary microvascular dysfunction evaluated by coronary flow reserve will be assessed.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: So Ree Kim, PhD
- Phone Number: 82-10-9453-4810
- Email: soree8826kim@gmail.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 02841
- Recruiting
- Korea University Anam Hospital
-
Principal Investigator:
- Seong-Mi Park
-
Sub-Investigator:
- Mi-Na Kim
-
Sub-Investigator:
- So Ree Kim
-
Contact:
- So Ree Kim, PhD
- Email: soree8826kim@gmail.com
-
Sub-Investigator:
- Dong-Hyuk Cho
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Typical/atypical chest pain or ischemic symptoms including dyspnea
- No significant coronary artery stenosis (<50% stenosis) in coronary angiography or computed tomography
Exclusion Criteria:
- ≥ Moderate valvular heart disease
- Congenital heart disease
- Chronic renal failure (estimated glomerular filtration rate <30 ml/min/1.73m2) or end-stage renal failure undergoing hemodialysis or peritoneal dialysis
- Asthma, chronic obstructive pulmonary disease and primary pulmonary hypertension
- Receiving anticancer drugs
- Vasculitis associated with autoimmune diseases
- Atrioventricular block with more than second degrees, symptomatic bradycardia, cryo-node failure syndrome, Wolff-Parkinson-White (WPW) patients
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
A composite outcome including all-cause mortality, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for heart failure
Time Frame: 1 year
|
Number of participants with a composite outcome including all-cause mortality, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for heart failure
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Seong-Mi Park, PhD, Korea University Anam Hospital
- Study Chair: Mi-Na Kim, PhD, Korea University Anam Hospital
- Study Chair: Dong-Hyuk Cho, PhD, Korea University Anam Hospital
- Study Chair: So Ree Kim, PhD, Korea University Anam Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Angina Pectoris
- Coronary Artery Disease
- Myocardial Ischemia
- Coronary Disease
- Microvascular Angina
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Vasodilator Agents
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Purinergic Agents
- Purinergic P1 Receptor Agonists
- Purinergic Agonists
- Adenosine
Other Study ID Numbers
- 2017AN0358
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microvascular Angina
-
Medstar Health Research InstituteRecruiting
-
Spanish Society of CardiologyRecruitingAngina, Stable | Coronary Microvascular Disease | Coronary Microvascular DysfunctionSpain
-
Peking University First HospitalRecruiting
-
University Hospital, GrenobleRecruitingCoronary Microvascular DiseaseFrance
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI); Astellas Pharma Global Development...Completed
-
Johannes Gutenberg University MainzNeovasc Inc.RecruitingRefractory Angina | Coronary Microvascular DiseaseGermany
-
Lisata Therapeutics, Inc.TerminatedCoronary Microvascular Disease | Coronary Microvascular Dysfunction | Microvascular Coronary Artery DiseaseUnited States
-
CoreAalst BVHexacath, FranceRecruiting
-
Qilu Hospital of Shandong UniversityNot yet recruitingCoronary Microvascular Disease
-
Qilu Hospital of Shandong UniversityNot yet recruitingCoronary Microvascular Disease
Clinical Trials on Adenosine stress echocardiography
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e...RecruitingRight Ventricular DysfunctionItaly
-
University of Missouri-ColumbiaCompletedObesity | Metabolic Syndrome
-
Hospices Civils de LyonRecruitingHereditary Hemorrhagic Telangiectasia | Rendu Osler DiseaseFrance
-
Medical University of ViennaUnknown
-
Centre Hospitalier Universitaire de NiceCompletedPulmonary HypertensionFrance
-
Mustafa Kemal UniversityCompletedHypertension | Left Ventricular HypertrophyTurkey
-
Technical University of MunichLudwig-Maximilians - University of MunichEnrolling by invitationCardiovascular Diseases | Pediatric CancerGermany
-
China Medical University HospitalUnknownCardiovascular Diseases | STEMI | NSTEMITaiwan
-
Mayo ClinicCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States